Test Bank for Pharmacology and the Nursing Process 8th Edition Lilley Collins Snyder Complete Chapters 1–58 Guide PDF Download

Test-Bank-Pharmacology-And-The-Nursing-Process-8th-
Edition-Linda-Lane-Lilley-Shelly-Rainforth-Collins-Julie-S.-
Snyder-Chapter-1-58-Complete-Guide (1)v




TESTBANK v

,TEST BANK FOR
v v




Pharmacology and the Nursing Process 8th Edition
v v v v v v




Linda LaneLilley,Shelly Rainforth Collins, Julie S. Snyder
v v v v v v v v




Contents
Chapter 01: The Nursing Process and Drug Therapy ......................................................................................... 4
v v v v v v v




Chapter 02: Pharmacologic Principles ............................................................................................................. 8
v v v




Chapter 03: Lifespan Considerations............................................................................................................. 14
v v v




Chapter 04: Cultural, Legal, and Ethical Considerations ................................................................................. 20
v v v v v v




Chapter05: Medication Errors: Preventing and Responding.......................................................................... 26
v v v v v v




Chapter 06: Patient Education and Drug Therapy .......................................................................................... 29
v v v v v v




Chapter07: Over-the-Counter Drugs and Herbal and Dietary Supplements ................................................... 34
v v v v v v v v




Chapter 08: Gene Therapy and Pharmacogenomics ...................................................................................... 38
v v v v v




Chapter 09: Photo Atlas ofDrug Administration ............................................................................................ 41
v v v v v v




Chapter10: Analgesic Drugs ......................................................................................................................... 50
v v v




Chapter 11: General and Local Anesthetics ................................................................................................... 57
v v v v v




Chapter12: Central Nervous System Depressants andMuscle Relaxants....................................................... 61
v v v v v v v v




Chapter13: Central Nervous System Stimulants and Related Drugs .............................................................. 66
v v v v v v v v




Chapter14: Antiepileptic Drugs .................................................................................................................... 70
v v v




Chapter15: AntiparkinsonDrugs .................................................................................................................. 76
v v v




Chapter16:Psychotherapeutic Drugs........................................................................................................... 81
v v v




Chapter17: Substance Abuse ....................................................................................................................... 88
v v v




Chapter 18: AdrenergicDrugs ....................................................................................................................... 93
v v v




Chapter19: Adrenergic-Blocking Drugs ........................................................................................................ 98
v v v




Chapter 20: Cholinergic Drugs .................................................................................................................... 103
v v v




Chapter21: Cholinergic-Blocking Drugs ...................................................................................................... 108
v v v




Chapter22: Antihypertensive Drugs ........................................................................................................... 113
v v v




Chapter23: Antianginal Drugs .................................................................................................................... 119
v v v




Chapter 24: Heart Failure Drugs .................................................................................................................. 125
v v v v




Chapter25: Antidysrhythmic Drugs ............................................................................................................ 131
v v v




Chapter26: CoagulationModifier Drugs ..................................................................................................... 137
v v v v




Chapter27: Antilipemic Drugs .................................................................................................................... 143
v v v

,Chapter 28: Diuretic Drugs .......................................................................................................................... 148
v v v




Chapter 29: Fluids and Electrolytes ............................................................................................................. 154
v v v v




Chapter30: Pituitary Drugs ......................................................................................................................... 160
v v v




Chapter 31: Thyroid and Antithyroid Drugs ................................................................................................. 163
v v v v v




Chapter32: AntidiabeticDrugs ................................................................................................................... 168
v v v




Chapter33: Adrenal Drugs .......................................................................................................................... 177
v v v




Chapter 34: Women’s Health Drugs ............................................................................................................ 181
v v v v




Chapter 35: Men’s HealthDrugs.................................................................................................................. 188
v v v v




Chapter36: Antihistamines, Decongestants, Antitussives, and Expectorants .............................................. 193
v v v v v v




Chapter37: Respiratory Drugs .................................................................................................................... 198
v v v




Chapter38: AntibioticsPart 1...................................................................................................................... 204
v v v v




Chapter39: AntibioticsPart 2...................................................................................................................... 211
v v v v




Chapter 40: AntiviralDrugs ......................................................................................................................... 216
v v v




Chapter41: AntitubercularDrugs ............................................................................................................... 221
v v v




Chapter42: Antifungal Drugs ...................................................................................................................... 226
v v v




Chapter43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs ............................................................... 231
v v v v v v




Chapter44: Anti-inflammatory and Antigout Drugs .................................................................................... 236
v v v v v




Chapter45: Antineoplastic Drugs Part1: Cancer Overview and Cell Cycle–SpecificDrugs ............................. 242
v v v v v v v v v v v




Chapter46: AntineoplasticDrugs Part2: Cell Cycle–Nonspecific Drugs andMiscellaneous Drugs ................. 248
v v v v v v v v v v v




Chapter47: Biologic Response–Modifyingand AntirheumaticDrugs .......................................................... 253
v v v v v v




Chapter48: Immunosuppressant Drugs ..................................................................................................... 258
v v v




Chapter49: Immunizing Drugs .................................................................................................................... 263
v v v




Chapter50: Acid-Controlling Drugs............................................................................................................. 268
v v v




Chapter 51: Bowel Disorder Drugs .............................................................................................................. 274
v v v v




Chapter 52: Antiemetic and Antinausea Drugs ............................................................................................ 281
v v v v v




Chapter 53: Vitamins and Minerals ............................................................................................................. 286
v v v v




Chapter 54: Anemia Drugs .......................................................................................................................... 292
v v v




Chapter 55: Nutritional Supplements ......................................................................................................... 299
v v v




Chapter56: DermatologicDrugs ................................................................................................................. 304
v v v




Chapter 57: OphthalmicDrugs .................................................................................................................... 310
v v v




Chapter 58: Otic Drugs ................................................................................................................................ 315
v v v

, Chapter 01:TheNursing Process and Drug Therapy v v v v v v v




MULTIPLE CHOICE v




1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been newly
v v v v v v v v v v v v v v v v v v




vdiagnosed with type 2 diabetes. Which statement reflects the correct format for a nursing
v v v v v v v v v v v v v




vdiagnosis?
a. Anxiety
b. Anxiety related to new drug therapy v v v v v




c. Anxietyrelated to anxious feelings about drug therapy, as evidenced bystatements
v v v v v v v v v v v




such as “I’m upset about having to test my blood sugars.”
v v v v v v v v v v v




d. Anxietyrelated to new drug therapy, as evidenced by statements such as “I’m
v v v v v v v v v v v v




upset about having to test my blood sugars.”
v v v v v v v v




ANS: D v




Formulation of nursing diagnoses is usually a three-step process. “Anxiety” is missing the “related
v v v v v v v v v v v v v




to” and “as evidenced by” portions of defining characteristics. “Anxiety related to new drugtherapy”
v v v v v v v v v v v v v v v




is missing the “as evidenced by” portion of defining characteristics. The statement beginning
v v v v v v v v v v v v v




“Anxiety related to anxious feelings” is incorrect because the “related to” section is simply a
v v v v v v v v v v v v v v v




restatement of the problem “anxiety,” not a separate factor related to the response.
v v v v v v v v v v v v v




DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: p.7 v v v v v




TOP: NURSING PROCESS: Nursing Diagnosis
v v v v v




MSC: NCLEX: Safe and Effective Care Environment:Management of Care
v v v v v v v v v




2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy and gave
v v v v v v v v v v v v v v v v v




v the medication 2 hours after the scheduled dose was due. What type of problem does this represent?
v v v v v v v v v v v v v v v v




a. “Right time” v




b. “Right dose” v




c. “Right route” v




d. “Right medication” v




ANS: A v




“Right time” is correct because the medication was given more than 30 minutes after the scheduled
v v v v v v v v v v v v v v v




dose was due. “Dose” is incorrect because the dose is not related to the time the medication
v v v v v v v v v v v v v v v v v




administration is scheduled. “Route” is incorrect because the route is not affected. “Medication” is
v v v v v v v v v v v v v v




incorrect because the medication ordered will not change.
v v v v v v v v




DIF: COGNITIVE LEVEL: Applying (Application) REF: p.11 v v v v v




TOP: NURSING PROCESS: Implementation
v v v v




MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
v v v v v v v v v v




3. The nurse has been monitoring the patient’s progress on a new drug regimen since the first dose and
v v v v v v v v v v v v v v v v v




documenting the patient’s therapeutic response to the medication. Which phase of the nursing
v v v v v v v v v v v v v




process do these actions illustrate?
v v v v v




a. Nursing diagnosis v